BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25381299)

  • 1. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
    Quintana FJ; Patel B; Yeste A; Nyirenda M; Kenison J; Rahbari R; Fetco D; Hussain M; O'Mahony J; Magalhaes S; McGowan M; Johnson T; Rajasekharan S; Narayanan S; Arnold DL; Weiner HL; Banwell B; Bar-Or A;
    Neurology; 2014 Dec; 83(24):2219-26. PubMed ID: 25381299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
    van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
    Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex antibody profiling to predict clinical outcome in childhood ADS.
    Hemmer B; Calabresi PA
    Neurology; 2014 Dec; 83(24):2200-1. PubMed ID: 25381297
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive and Behavioral Functioning in Childhood Acquired Demyelinating Syndromes.
    Till C; Noguera A; Verhey LH; O'Mahony J; Yeh EA; Mah JK; Sinopoli KJ; Brooks BL; Aubert-Broche B; Collins DL; Narayanan S; Arnold DL; Banwell BL
    J Int Neuropsychol Soc; 2016 Nov; 22(10):1050-1060. PubMed ID: 27903328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acquired demyelination of the CNS in Canadian children.
    Banwell B; Kennedy J; Sadovnick D; Arnold DL; Magalhaes S; Wambera K; Connolly MB; Yager J; Mah JK; Shah N; Sebire G; Meaney B; Dilenge ME; Lortie A; Whiting S; Doja A; Levin S; MacDonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Guimond C; Cooper P; Grand'Maison F; Baird JB; Bhan V; Bar-Or A
    Neurology; 2009 Jan; 72(3):232-9. PubMed ID: 19153370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice.
    Ahn JJ; O'Mahony J; Moshkova M; Hanwell HE; Singh H; Zhang MA; Marrie RA; Bar-Or A; Sadovnick DA; Dunn SE; Banwell BL
    Mult Scler; 2015 May; 21(6):735-48. PubMed ID: 25533291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
    Tillema JM; Leach J; Pirko I
    Mult Scler; 2012 Dec; 18(12):1754-9. PubMed ID: 22641299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.
    Wong YYM; van der Vuurst de Vries RM; van Pelt ED; Ketelslegers IA; Melief MJ; Wierenga AF; Catsman-Berrevoets CE; Neuteboom RF; Hintzen RQ
    Mult Scler; 2018 Nov; 24(13):1715-1724. PubMed ID: 30019626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery From Central Nervous System Acute Demyelination in Children.
    O'Mahony J; Marrie RA; Laporte A; Yeh EA; Bar-Or A; Phan C; Buckley D; Callen D; Connolly MB; Pohl D; Dilenge ME; Bernard G; Lortie A; Lowry N; MacDonald EA; Meek D; Sébire G; Venkateswaran S; Wood E; Yager J; Banwell B
    Pediatrics; 2015 Jul; 136(1):e115-23. PubMed ID: 26034241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
    O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
    J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI features of pediatric multiple sclerosis.
    Banwell B; Shroff M; Ness JM; Jeffery D; Schwid S; Weinstock-Guttman B;
    Neurology; 2007 Apr; 68(16 Suppl 2):S46-53. PubMed ID: 17438238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.
    de Mol CL; Wong YYM; van Pelt ED; Ketelslegers IA; Bakker DP; Boon M; Braun KPJ; van Dijk KGJ; Eikelenboom MJ; Engelen M; Geleijns K; Haaxma CA; Niermeijer JMF; Niks EH; Peeters EAJ; Peeters-Scholte CMPCD; Poll-The BT; Portier RP; de Rijk-van Andel JF; Samijn JPA; Schippers HM; Snoeck IN; Stroink H; Vermeulen RJ; Verrips A; Visscher F; Vles JSH; Willemsen MAAP; Catsman-Berrevoets CE; Hintzen RQ; Neuteboom RF
    J Neurol; 2018 Jun; 265(6):1310-1319. PubMed ID: 29569176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk.
    Lavery AM; Collins BN; Waldman AT; Hart CN; Bar-Or A; Marrie RA; Arnold D; O'Mahony J; Banwell B
    Mult Scler; 2019 Apr; 25(4):515-522. PubMed ID: 29393768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
    Hintzen RQ; Dale RC; Neuteboom RF; Mar S; Banwell B
    Neurology; 2016 Aug; 87(9 Suppl 2):S67-73. PubMed ID: 27572864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.